Viewing Study NCT03016104


Ignite Creation Date: 2025-12-24 @ 9:07 PM
Ignite Modification Date: 2026-01-02 @ 6:25 AM
Study NCT ID: NCT03016104
Status: WITHDRAWN
Last Update Posted: 2022-05-11
First Post: 2016-12-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Magnetic Seizure Therapy vs. Electroconvulsive Therapy for Bipolar Mania
Sponsor: Shanghai Mental Health Center
Organization:

Study Overview

Official Title: Magnetic Seizure Therapy vs. Electroconvulsive Therapy for Bipolar Mania
Status: WITHDRAWN
Status Verified Date: 2022-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: The problems of MST device
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This trial attempts to evaluate the treatment efficacy of magnetic seizure therapy (MST) and its safety for bipolar mania. Half of the participants will receive MST, while the other half will receive electroconvulsive therapy (ECT).
Detailed Description: Magnetic seizure therapy (MST) is likely to be an alternative options to electroconvulsive therapy (ECT).

Widespread stimulation of cortical and subcortical regions is inevitable for ECT since the substantial impedance of the scalp and skull shuts most of the electrical stimulus away from the brain. Nevertheless, magnetic pulses are capable to focus the stimulus to a specific area of the brain because they can pass the scalp and skull without resistance. In Addition, electric current will penetrate into deeper structures, while magnetic stimulus are only capable to reach a depth of a few centimeters. As a consequence, MST are able to generate focus stimuli on superficial regions of the cortex while ECT can't, which may give MST the capability to produce comparable therapeutic benefits with the absence of apparent cognitive side effects.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: